TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21081229

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of aerobic and resistance exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 0
Study: 19379588

Group type: EXPERIMENTAL
Intervention: CHG regimen (homoharringtonine, cytarabine, G-CSF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CAG regimen (aclarubicin/Ara-C, G-CSF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: HA regimen (HHT/Ara-C, G-CSF)
Number of subjects: 30
Study: 17321919

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 70
Study: 15342154

Group type: EXPERIMENTAL
Intervention: Sensor-based estimation using a rigid trunk model
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sensor-based estimation using a segmented trunk model
Number of subjects: 5

Group type: COMPARATOR
Intervention: Position and force data method (control)
Number of subjects: 5
Study: 11176553

Group type: EXPERIMENTAL
Intervention: One-to-one education
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Group education
Number of subjects: 595

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: One-to-one education with reminders
Number of subjects: 595
Study: 10633736

Group type: EXPERIMENTAL
Intervention: Educational intervention on the nursing process and documentation according to the VIPS model
Number of subjects: 120

Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 120
Study: 7802307

Group type: EXPERIMENTAL
Intervention: Clonidine (75 micrograms) and Morphine (0.5 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Morphine (0.5 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.9% Sodium Chloride (Control)
Number of subjects: 90
Study: 2312234

Group type: EXPERIMENTAL
Intervention: Third- and fourth-year student nurses and registered nurses
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Third- and fourth-year student nurses
Number of subjects: 24

Group type: COMPARATOR
Intervention: First-year student nurses
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nurses with nursing experience
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nurses assessing patients with physical pathology
Number of subjects: 24
Study: 7001044

Group type: EXPERIMENTAL
Intervention: Povidone-iodine gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 50
Study: 30367470

Group type: EXPERIMENTAL
Intervention: Flexitheralight protocol (n = 156 AKs)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional protocol (Aktilite CL 128 lamp) (n = 154 AKs)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Flexitheralight protocol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional protocol (Aktilite CL 128 lamp)
Number of subjects: 25
Study: 27463536

Group type: EXPERIMENTAL
Intervention: Inform Me mobile Web application after routine transplant education
Number of subjects: 288

Group type: COMPARATOR
Intervention: Routine transplant education alone
Number of subjects: 288
Study: 24548259

Group type: EXPERIMENTAL
Intervention: Liquid energy intake (1 MJ day(-1))
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Solid energy intake
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverages (SSB) consumption (100 g day(-1))
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Diet drinks (100 g day(-1))
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Substitution of 100 g of SSB by 100 g of water or diet drink
Number of subjects: 158
Study: 23706327

Group type: EXPERIMENTAL
Intervention: Heart rate ≥70 bpm
Number of subjects: 18980

Group type: EXPERIMENTAL
Intervention: Heart rate as a continuous variable
Number of subjects: 18980
Study: 21718836

Group type: EXPERIMENTAL
Intervention: Leukocyte filtration (LF)
Number of subjects: 60
Study: 19938555

Group type: EXPERIMENTAL
Intervention: Bushen Jianpi Huoxue Paidu
Number of subjects: 0
Study: 17966760

Group type: EXPERIMENTAL
Intervention: Thyme-primrose combination (1 tablet three times daily for 11 days)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Thyme-primrose combination
Number of subjects: 361

Group type: COMPARATOR
Intervention: Thyme-primrose combination and Placebo
Number of subjects: 361
Study: 15194515

Group type: EXPERIMENTAL
Intervention: Group Psychotherapy and Home‐Based Physical Exercise (GROUP‐HOPE)
Number of subjects: 51
Study: 11435811

Group type: EXPERIMENTAL
Intervention: P13-like potentials after P11 with noncephalic reference
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Delayed true P13/14s followed by N18s
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Lower cervical P13 (lcP13)
Number of subjects: 5
Study: 11669215

Group type: EXPERIMENTAL
Intervention: Granulocyte colony‐stimulating factor (G‐CSF)‐stimulated peripheral blood mononuclear cells (GPBMC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bone marrow (BM)
Number of subjects: 0
Study: 9422416

Group type: EXPERIMENTAL
Intervention: TAC-MMF
Number of subjects: 71

Group type: COMPARATOR
Intervention: CsA-MMF
Number of subjects: 71
Study: 8487122

Group type: EXPERIMENTAL
Intervention: Self-care brochures
Number of subjects: 14917
Study: 3112024

Group type: EXPERIMENTAL
Intervention: Pseudomonas hyperimmune globulin (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study: 2102067

Group type: EXPERIMENTAL
Intervention: PDRN 1.65 mg vaginal suppositories
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PDRN 5 mg vaginal suppositories
Number of subjects: 40

Group type: COMPARATOR
Intervention: PDRN (both dosages)
Number of subjects: 40
Study: 238429

Group type: EXPERIMENTAL
Intervention: Midline incision
Number of subjects: 48

Group type: COMPARATOR
Intervention: Transverse incision
Number of subjects: 48
Study: 31275442

Group type: EXPERIMENTAL
Intervention: Circulating levels of miR-574-5p measured by quantitative PCR in plasma samples collected 48 hours after cardiac arrest.
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Circulating levels of miR-574-5p after adjustment with clinical variables and NSE.
Number of subjects: 590
Study: 28931166

Group type: EXPERIMENTAL
Intervention: Harvest of the Month (HOTM) program
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 275
Study: 26012585

Group type: EXPERIMENTAL
Intervention: STEEP-b plus treatment as usual (TAU)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 120
Study: 25349392

Group type: EXPERIMENTAL
Intervention: Discrimination of fearful and nonfearful eyes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discrimination of direct and averted gaze
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response to human sclera
Number of subjects: 0
Study: 22595313

Group type: EXPERIMENTAL
Intervention: secukinumab (2×10 mg/kg intravenous)
Number of subjects: 59

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: secukinumab
Number of subjects: 59
Study: 20013559

Group type: EXPERIMENTAL
Intervention: High glycemic index meal (HGI, GI=77)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low glycemic index meal (LGI, GI=37)
Number of subjects: 7
Study: 17304885

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 37
Study: 15347716

Group type: EXPERIMENTAL
Intervention: SUV (Standardized Uptake Value)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: KPat (Fluoride bone influx rate obtained by Patlak analysis)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: KNLR (Fluoride bone influx rate obtained by nonlinear regression)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Changes in metabolic values of the grafts for KPat and KNLR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Changes in metabolic values of the grafts for KPat and SUV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Changes in metabolic values of the grafts for KNLR and SUV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 95% range of normal change in limb bones for SUV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 95% range of normal change in limb bones for KPat
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 95% range of normal change in limb bones for KNLR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 95% range of normal change in spine for SUV
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 95% range of normal change in spine for KPat
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 95% range of normal change in spine for KNLR
Number of subjects: 33
Study: 12040215

Group type: EXPERIMENTAL
Intervention: Osteogenic device (OD)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Autologous bone grafts (ABGs)
Number of subjects: 13
Study: 9810576

Group type: EXPERIMENTAL
Intervention: PCR TKA
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PS TKA
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: ACLD knee
Number of subjects: 57

Group type: COMPARATOR
Intervention: Normal knee
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Simulated walking conditions
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Maximum separation in PCR knee
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Patellofemoral impact force
Number of subjects: 57
Study: 7759676

Group type: EXPERIMENTAL
Intervention: Behavioral and cognitive-behavioral therapy methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific, focused therapy methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured therapy with treatment manuals and monitoring
Number of subjects: 0
Study: 2539203

Group type: EXPERIMENTAL
Intervention: Efamol (evening primrose oil containing gamma-linolenic acid, with vitamin E as preservative) - 8 capsules per day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: D-amphetamine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 190671

Group type: EXPERIMENTAL
Intervention: Sodium fluoride dentifrice
Number of subjects: 400

Group type: COMPARATOR
Intervention: Sodium monofluorophosphate dentifrice
Number of subjects: 400
Study: 31653400

Group type: EXPERIMENTAL
Intervention: Gold alloy against rough-surface zirconia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Co-Cr alloy against smooth-surface zirconia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rough-surface monolithic zirconia
Number of subjects: 60
Study: 30485425

Group type: EXPERIMENTAL
Intervention: Inhibition of arginine metabolism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement of plasma arginine concentrations
Number of subjects: 0
Study: 28260986

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 72
Study: 25757593

Group type: EXPERIMENTAL
Intervention: 600 mg/d pure hesperidin supplement
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 23497761

Group type: EXPERIMENTAL
Intervention: Fentanyl Sublingual Spray (FSS) 400 μg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oral Transmucosal Fentanyl Citrate (OTFC) 400 μg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Intravenous Fentanyl Citrate 100 μg
Number of subjects: 29
Study: 22439299

Group type: EXPERIMENTAL
Intervention: Spirituality Teaching Program Group (8 week, home‐based Spirituality Teaching Program)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Waitlist Control Group (no intervention followed by Spirituality Teaching Program starting at week 9)
Number of subjects: 84
Study: 19699472

Group type: EXPERIMENTAL
Intervention: Tolcapone (200 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 16879763

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 479
Study: 14767306

Group type: EXPERIMENTAL
Intervention: Multimedia program (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard lecture (group 2)
Number of subjects: 60
Study: 11593078

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate, sustained-release capsules (15 to 30 mg initially, increased to 30 mg or 60 mg at week 5)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate, sustained-release capsules (30 to 60 mg)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 128
Study: 9647058

Group type: EXPERIMENTAL
Intervention: Intermittent antegrade tepid blood cardioplegia (29 degrees C)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cold blood cardioplegia (4 degrees C)
Number of subjects: 52
Study: 7915845

Group type: EXPERIMENTAL
Intervention: Ipsapirone 5.0mg tid
Number of subjects: 267

Group type: COMPARATOR
Intervention: Ipsapirone 2.5mg tid
Number of subjects: 267

Group type: COMPARATOR
Intervention: Ipsapirone 7.5mg tid
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 2513050

Group type: EXPERIMENTAL
Intervention: Four meals a day including a late evening meal (2300)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Six meals a day including a late evening meal (2300)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Three meals a day
Number of subjects: 9
Study: 4427449

Group type: EXPERIMENTAL
Intervention: 2.5% grade treadmill running
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 5.0% grade treadmill running
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 7.5% grade treadmill running
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Progressive treadmill running
Number of subjects: 7
Study: 31574108

Group type: EXPERIMENTAL
Intervention: Badminton training course for 12 weeks
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (no regular ball sports during the period)
Number of subjects: 2
Study: 30180273

Group type: EXPERIMENTAL
Intervention: CaCO3 1200 mg/day with 10,000 IU vitamin D3/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: CaCO3 1200 mg/day with 600 IU vitamin D3/day
Number of subjects: 48
Study: 26654135

Group type: EXPERIMENTAL
Intervention: Oral ondansetron (n = 85)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo (n = 85)
Number of subjects: 170
Study: 24485947

Group type: EXPERIMENTAL
Intervention: Affective communication during bad news consultation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard communication during bad news consultation
Number of subjects: 50
Study: 22302704

Group type: EXPERIMENTAL
Intervention: Crude extracts from Commiphora swynnertonii (various concentrations)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Crude extracts from Commiphora swynnertonii (500 μg/mL resin extract)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Crude extracts from Commiphora swynnertonii (resin and root bark extracts)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Positive control (inoculated with NDV without treatment)
Number of subjects: 6
Study: 19150495

Group type: EXPERIMENTAL
Intervention: Fish oil containing 3.7 g/day n‐3 polyunsaturated fatty acid (n‐3PUFA)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Fish oil containing 3.7 g/day n‐3PUFA
Number of subjects: 83
Study: 17229227

Group type: EXPERIMENTAL
Intervention: NSCF during intubation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RE-Delta during intubation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NSCF pre-stimuli vs post-stimuli during tetanic stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: NSCF R+ vs R- during tetanic stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RE-Delta during tetanic stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RE during emergence
Number of subjects: 20
Study: 14745054

Group type: EXPERIMENTAL
Intervention: Unilateral pallidotomy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bilateral STN stimulation
Number of subjects: 34
Study: 11668094

Group type: EXPERIMENTAL
Intervention: Standard information (diagnosis, circumstances surrounding injury, and disposal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional information (standard information plus place of injury, number of A&E attendances for injury in previous year, and any information recorded about safety equipment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Notifications for selected attendances
Number of subjects: 0

Group type: COMPARATOR
Intervention: Notifications for all attendances
Number of subjects: 0
Study: 9676464

Group type: EXPERIMENTAL
Intervention: MRI with Gd-enhanced FLASH sequence
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MRI with T2-weighted fat saturation technique
Number of subjects: 44

Group type: COMPARATOR
Intervention: MRI without contrast
Number of subjects: 44
Study: 8207699

Group type: EXPERIMENTAL
Intervention: Sandimmune Neoral (180 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sandimmune (300 mg)
Number of subjects: 24
Study: 2914336

Group type: EXPERIMENTAL
Intervention: 3 ml.kg‐1 of apple juice given 2.6 +/‐ 0.4 hours preoperatively
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no apple juice)
Number of subjects: 80
Study: 1173614

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 261
Study: 31575326

Group type: EXPERIMENTAL
Intervention: Tropisetron (5 mg twice daily) and fluvoxamine (100 mg daily initially followed by 200 mg daily after week 4)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo and fluvoxamine (100 mg daily initially followed by 200 mg daily after week 4)
Number of subjects: 108
Study: 27929709

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal system (BTDS)
Number of subjects: 6566

Group type: COMPARATOR
Intervention: Buprenorphine transdermal system (BTDS) and active controls (oxycodone/acetaminophen [OXY/APAP] and hydrocodone/acetaminophen [HCD/APAP])
Number of subjects: 6566
Study: 25659147

Group type: EXPERIMENTAL
Intervention: Exercise and MFGM supplementation (Ex+MFGM)
Number of subjects: 131

Group type: COMPARATOR
Intervention: MFGM supplementation
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Exercise and placebo (Ex+Plac)
Number of subjects: 131
Study: 24046924

Group type: EXPERIMENTAL
Intervention: Structured education pulmonary rehabilitation programme
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 20
Study: 21106713

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 18831530

Group type: EXPERIMENTAL
Intervention: Istradefylline 20 mg once daily
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study: 16897238

Group type: EXPERIMENTAL
Intervention: Sevoflurane-fentanyl anesthesia (SF)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fentanyl-free sevoflurane anesthesia (S)
Number of subjects: 51
Study: 12761422

Group type: EXPERIMENTAL
Intervention: Cefadroxil prophylaxis at 12.5-15.0 mg/kg at bedtime every night (group I, n=15)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cefadroxil prophylaxis at 12.5-15.0 mg/kg at bedtime every alternate night (group II, n=18)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cefadroxil prophylaxis (both groups)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cefadroxil prophylaxis
Number of subjects: 33
Study: 11205194

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily for 4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8980795

Group type: EXPERIMENTAL
Intervention: Theo-Dur
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Theo-24
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Xanthium
Number of subjects: 12

Group type: COMPARATOR
Intervention: Aminophylline (IV)
Number of subjects: 12
Study: 8511308

Group type: EXPERIMENTAL
Intervention: Low-dose radiation therapy (5 fractions of 2 Gy each)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: High-dose radiation therapy (10 fractions of 2 Gy each)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: High-dose radiation therapy (5 fractions of 3.5 Gy each)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiinflammatory drug (NSAID) use
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: High RT dose with short duration (< or = 9 days)
Number of subjects: 137
Study: 3551401

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pyrazolone (intramuscularly and intravenously)
Number of subjects: 60
Study: 31628574

Group type: EXPERIMENTAL
Intervention: Procedural coagulation scenarios
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Peri-procedural coagulation parameters (platelet count and fibrinogen level)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anticoagulation for mesenteric vein thrombosis in liver transplant candidates
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anticoagulation in non-liver transplant candidates with mesenteric vein thrombosis
Number of subjects: 20
Study: 28917523

Group type: EXPERIMENTAL
Intervention: Kinesio taping with skin convolutions
Number of subjects: 148

Group type: COMPARATOR
Intervention: Kinesio taping without convolutions (Sham Taping)
Number of subjects: 148
Study: 24889273

Group type: EXPERIMENTAL
Intervention: Tisseel/Tissucol
Number of subjects: 316

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 316
Study: 22672081

Group type: EXPERIMENTAL
Intervention: LM25 therapy (25% insulin lispro, 75% insulin lispro protamine suspension)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Glargine + insulin lispro therapy
Number of subjects: 426
Study: 20920236

Group type: EXPERIMENTAL
Intervention: Oxycodone PR/naloxone PR (n = 292)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Oxycodone PR (n = 295)
Number of subjects: 587
Study: 18772509

Group type: EXPERIMENTAL
Intervention: Simvastatin combined with routine treatment (beta receptor blocker, calcium-channel blocker, long active nitrate)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Simvastatin combined with routine treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine treatment (beta receptor blocker, calcium-channel blocker, long active nitrate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 40